Cargando…
PPARα Ligand-Binding Domain Structures with Endogenous Fatty Acids and Fibrates
Most triacylglycerol-lowering fibrates have been developed in the 1960s–1980s before their molecular target, peroxisome proliferator-activated receptor alpha (PPARα), was identified. Twenty-one ligand-bound PPARα structures have been deposited in the Protein Data Bank since 2001; however, binding mo...
Autores principales: | Kamata, Shotaro, Oyama, Takuji, Saito, Kenta, Honda, Akihiro, Yamamoto, Yume, Suda, Keisuke, Ishikawa, Ryo, Itoh, Toshimasa, Watanabe, Yasuo, Shibata, Takahiro, Uchida, Koji, Suematsu, Makoto, Ishii, Isao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653058/ https://www.ncbi.nlm.nih.gov/pubmed/33205029 http://dx.doi.org/10.1016/j.isci.2020.101727 |
Ejemplares similares
-
Preparation of co-crystals of human PPARα-LBD and ligand for high-resolution X-ray crystallography
por: Kamata, Shotaro, et al.
Publicado: (2021) -
Current Clinical Trial Status and Future Prospects of PPAR-Targeted Drugs for Treating Nonalcoholic Fatty Liver Disease
por: Kamata, Shotaro, et al.
Publicado: (2023) -
Functional and Structural Insights into Human PPARα/δ/γ Subtype Selectivity of Bezafibrate, Fenofibric Acid, and Pemafibrate
por: Honda, Akihiro, et al.
Publicado: (2022) -
Functional and Structural Insights into the Human PPARα/δ/γ Targeting Preferences of Anti-NASH Investigational Drugs, Lanifibranor, Seladelpar, and Elafibranor
por: Kamata, Shotaro, et al.
Publicado: (2023) -
Lagrangian Fibrations
por: Huybrechts, D., et al.
Publicado: (2022)